A new gene editing company, Seamless Therapeutics, has launched in Germany with $12.5 million in seed financing from investors including Wellington Partners and 16 March 2023
Industry analyst Future Market Insights has forecast that the global market for psychedelic medicines, which it estimates to be currently worth $ 3.1 billion, w 14 March 2023
The trade group for UK-based drugmakers, the Association of the British Pharmaceutical Industry (ABPI), has appointed vice president Susan Rienow to the role of 9 March 2023
Gene therapy company Voyager Therapeutics has received a milestone payment of $25 million after Novartis exercised its options to license two novel capsids. 6 March 2023
US biopharma company Incyte announced late Friday that it will discontinue its Phase III LIMBER-304 trial, sending its share price 2% lower early in Monday’s tr 6 March 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.